Imfinzi
FDA Approves Imfinzi for Muscle-Invasive Bladder Cancer
The FDA has approved Imfinzi with gemcitabine and cisplatin as neoadjuvant treatment for adults with ...
APRIL 1, 2025
FDA Approves Imfinzi for Limited-Stage Small Cell Lung Cancer
The FDA approved Imfinzi for adults with limited-stage small cell lung cancer whose disease has not progressed ...
DECEMBER 6, 2024
FDA Approves Imfinzi and Imjudo Combo for Metastatic NSCLC
In the United States, lung cancer is the second most commonly diagnosed cancer, with more than 236,000 patients ...
NOVEMBER 14, 2022
Imfinzi Approved for First-Line Treatment of Extensive-Stage SCLC
The FDA approved durvalumab (Imfinzi, AstraZeneca) in combination with etoposide and either carboplatin or ...
APRIL 6, 2020
Load more